Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Short selling could very well be the reason for 30% decline
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(122)
•••
Comment by fdfd12on Jan 25, 2016 7:46pm
157 Views
Post# 24492302

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Short selling could very well be the reason for 30% decline

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Short selling could very well be the reason for 30% decline
That is funny. Because fo the board, he will sell tomorrow.
That is the most BS I have heard on this board.
It is probably notwrong pretending not to speak english.

Too funny guys.
Great imagination by him though.
Got to handed to him for cleverness.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities